GUIDELINES FOR USING CESA CLEAN ADDITIVES • Cesa Clean works best when molded maintaining normal (injection) pressure/shear • For best results, Avient recommends a “Running Color Change” which eliminates breaks in the molding cycle • Since the Cesa Clean concentrate will expand, it is recommended to reduce the shot size by 20% • It is designed for use at a let-down ratio (LDR) of 3.0% or (33:1); however, use rate can vary depending on the severity of the contamination but typically is 2.0–4.0% (a use rate higher than 6.0% may not have any positive affect on the cleaning performance) • Using Cesa Clean as a routine part of your color change rotation will allow faster changes and consume a minimal amount of raw material - Note: If the manifold is not cleaned routinely, this process may be more time consuming and additional material will be required • It is best to process at your normal polymer processing temperatures - For best performance, stock temperature should be at least 400°F - If 400°F is achieved during the purging process, no additional activation will occur during the reprocessing of regrind - All parts produced during the “Running Purge Cycle” should be captured as regrind, resulting in a scrap-free color change - If using sequential gates, open and close all gates at the same time while purging the tool - If contamination appears to be coming from one gate, open and close first, and for an extended period of time, to force more material through this location - When cleaning in this manner, pay close attention to shot size - Parts containing the previous or new color plus any Cesa Clean can be used as regrind INTRODUCING CESA CLEAN TO YOUR PROCESS Hand Blend • Hand weigh enough of the Cesa Clean and natural resin mix to equate to 3–5 times the barrel capacity • Use rate should be 3.0% or 33:1 for routine cleaning • For difficult-to-clean tooling, or tooling which is not routinely cleaned, start at 4.0% or 25:1 • Note: Do not attempt to vacuum load more than 15 feet from source as stratification/separation may occur Volumetric Feeder • Calibrate feeder to dispense 3.0% or 33:1 for routine cleaning • For difficult-to-clean tooling, or tooling which is not routinely cleaned, start at 4.0% or 25:1 • This style of feeder is highly recommended for at-the-throat metering of Cesa Clean Blending Units Most blenders have an extra bin for an additive • Fill the additive bin with Cesa Clean • Set blender to introduce the Cesa Clean at 2.0 to 4.0% • Note: Do not air convey any further than 15 feet as Cesa Clean has a high density and may separate from the mix. Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication of performance or properties obtained or obtainable on larger-scale equipment.

Your colors can be consistently reproduced from any Avient facility worldwide. 1 2 VISIT ONE OF OUR SELECT FACILITIESAlternatively, you can visit one of our global Select development facilities and work with one of our experts to create your color, produce and approve samples all in the same day. Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication of performance or properties obtained or obtainable on larger-scale equipment.

Side-by-sides can also enable farmers with the utility they need to work smarter, faster and stronger. Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication of performance or properties obtained or obtainable on larger-scale equipment.

Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication of performance or properties obtained or obtainable on larger-scale equipment. Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication of performance or properties obtained or obtainable on larger-scale equipment.

INDUSTRY BULLETIN DISPERSIONS IN HEALTHCARE TECHNOLOGY DESCRIPTION TYPICAL APPLICATIONS Silicone Colorant Dispersions Biocompatible, conformable silicone rubber colorants that deliver lightfastness and aesthetic appeal • 3D medical silicone printing • Anatomical models and surgical guides • External prosthetics and orthotics • Wearable medical devices • Medical ventilation/respiratory masks • Dental and medical tools and equipment • Catheters and tubing • Medical adhesives Silicone Additive Dispersions Silicone additive solutions formulated to provide chemical resistance, durability, and enhanced physical properties Rubber Colorant Dispersions Durable rubber colorants formulated for optimal dispersion and lot-to-lot consistency to promote ease of handling • Medical devices and tools • Vibration and shock control for medical equipment • Drug delivery devices Urethane Colorant Dispersions Versatile urethane colorants that streamline production and enhance quality • Medical packaging • Foam enclosures/support for medical tools and equipment • Medical and surgical devices • Physical therapy tools Epoxy Colorant Dispersions Long-lasting, hygienic epoxy colorants that provide high-cost efficiency, stability, and customization opportunities • Medical adhesives • Healthcare facility floor coatings Vinyl Colorant Dispersions Vinyl colorants developed for applications where dispersion, uniformity, compatibility, and cleanliness are essential • Catheters and tubing • Medical equipment Aqueous Additive Formulations Functional additives stabilized, suspended, and dispersed in water that shorten development cycles, streamline operations, and can be customized to meet specific requirements • Medical gloves • Wound care Electrically Conductive Additives for Silicone Innovative silicone additives to provide high conductivity and lower filler loadings • Wearable medical devices • Neurostimulation electrode pads • Medical tools and equipment Laser Marking Additives for Silicone Dispersions containing laser absorbers and color formers that eliminate the need for secondary etching while promoting chemical resistance, mechanical property retention, and production efficiency • Medical packaging • 3D medical silicone printing • Anatomical models and surgical guides • External prosthetics and orthotics • Medical ventilation/respiratory masks • Medical devices Surface Modification Additives for Silicone Non-oil based silicone additives that reduce tackiness and enhance smoothness of the cured compound • Catheters and tubing • Dental tools and equipment • Medical adhesives • Medical devices, tools, and equipment Self-Bonding Silicone Silicone compounds able to bond to various substrates without prime coating • Medical tools and equipment • Wearable medical devices • Medical packaging This listing represents standard Avient dispersion technologies and addresses common healthcare applications, but we can work with you to explore additional options. Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication of performance or properties obtained or obtainable on larger-scale equipment.

To enhance its ability to more accurately predict part performance, Avient worked with Hexagon’s Digimat platform. We are putting data to work to boost efficiency, productivity, quality and safety across industrial, manufacturing, infrastructure, public sector, and mobility applications.

 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation  Strong past performance demonstrates that our strategy and execution are working  Megatrends and emerging opportunities align with our strengths  Innovation and services provide differentiation, incremental pricing power, and competitive advantage  Strong and proven management team driving growth and performance  Addressable market exceeds $40 billion 1 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Senior management uses adjusted operating income, adjusted EPS, and working capital to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.

 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation  Strong past performance demonstrates that our strategy and execution are working  Megatrends and emerging opportunities align with our strengths  Innovation and services provide differentiation, incremental pricing power, and competitive advantage  Strong and proven management team driving growth and performance  Addressable market exceeds $40 billion 1 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Senior management uses adjusted operating income, adjusted EPS, and working capital to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.

 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limita tion, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged a nd those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, chang es in interest rates and changes in the rate of inflation  Strong past performance demonstrates that our strategy and execution are working  Megatrends and emerging opportunities align with our strengths  Innovation and services provide differentiation, incremental pricing power, and competitive advantage  Strong and proven management team driving growth and performance  Addressable market exceeds $40 billion Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Senior management uses adjusted operating income, adjusted EPS, and working capital to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned manufacturing realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation  Strong past performance demonstrates that our strategy and execution are working  Megatrends and emerging opportunities align with our strengths  Innovation and services provide differentiation, incremental pricing power, and competitive advantage  Strong and proven management team driving growth and performance  Addressable market exceeds $40 billion Page 15 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Senior management uses adjusted operating income, adjusted EPS, and working capital to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.